Shots:
Jazz Pharmaceuticals and partners presented seven abstracts from their oncology development program at ASCO 2025
Robert Iannone, CMO, EVP, Global Head of Research and Development, and Chief Medical Officer at Jazz Pharmaceuticals, in an engaging discussion with PharmaShots, shared four-year follow-up data from an ongoing P-II trial of Ziihera in combination with CT for…
